Xylogenics
2008
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Conv. Debt
LATEST DEAL TYPE
$525K
LATEST DEAL AMOUNT
Description
Provider of a yeast genomics platform. The company is engaged in the the engineering of modified yeast microorganisms to synthesize commercial chemicals.
Primary Industry
Biotechnology
Primary Office
- 351 West 10th Street
- Indianapolis, IN 46202
- United States
+1 (317) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Xylogenics’s full profile, request a free trial.
Xylogenics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Convertible Debt | 20-Dec-2010 | $525K | 00000 | Completed | Startup |
Xylogenics Executive Team (5)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Joshua Heyen Ph.D | Chief Executive Officer, President & Co-Founder | ||
| Matt Kelker Ph.D | Chief Scientific Officer | ||
| Cary Woods | Co-Founder |
2 Former Executives
You’re viewing 3 of 5 executives. Get the full list »